MARKET

CGEN

CGEN

Compugen
NASDAQ
1.670
-0.030
-1.76%
Closed 18:41 07/09 EDT
OPEN
1.720
PREV CLOSE
1.700
HIGH
1.730
LOW
1.660
VOLUME
113.60K
TURNOVER
0
52 WEEK HIGH
2.660
52 WEEK LOW
1.130
MARKET CAP
156.17M
P/E (TTM)
-10.7326
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CGEN last week (0630-0704)?
Weekly Report · 3d ago
Weekly Report: what happened at CGEN last week (0623-0627)?
Weekly Report · 06/30 09:39
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
NASDAQ · 06/24 18:07
Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?
NASDAQ · 06/24 14:42
Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength?
NASDAQ · 06/24 14:40
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
NASDAQ · 06/24 14:38
RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains?
NASDAQ · 06/24 11:56
Graham (GHM) Surges 7.4%: Is This an Indication of Further Gains?
NASDAQ · 06/24 11:50
More
About CGEN
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

Webull offers Compugen Ltd (USA) stock information, including NASDAQ: CGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CGEN stock methods without spending real money on the virtual paper trading platform.